These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34066044)

  • 1. Frequency of
    Massari G; Magnoni F; Favia G; Peradze N; Veronesi P; La Vecchia C; Corso G
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34066044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDH1 germline mutations in families with hereditary lobular breast cancer.
    Girardi A; Magnoni F; Vicini E; Kouloura A; La Vecchia C; Veronesi P; Corso G
    Eur J Cancer Prev; 2022 May; 31(3):274-278. PubMed ID: 33990097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
    Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
    J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
    Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
    Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review.
    Corso G; Corso F; Bellerba F; Carneiro P; Seixas S; Cioffi A; La Vecchia C; Magnoni F; Bonanni B; Veronesi P; Gandini S; Figueiredo J
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Corso G; Magnoni F; Massari G; Trovato CM; De Scalzi AM; Vicini E; Bonanni B; Veronesi P; Galimberti V; Bagnardi V
    J Med Genet; 2022 Apr; 59(4):313-317. PubMed ID: 34952833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment.
    Luo W; Fedda F; Lynch P; Tan D
    Front Pharmacol; 2018; 9():1421. PubMed ID: 30568591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
    Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
    Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer.
    Aronson M; Swallow C; Govindarajan A; Semotiuk K; Cohen Z; Kaurah P; Velsher L; Ambus I; Buckley K; Forster-Gibson C; Meschino WS; Blumenthal A; Kim RH; Brar S
    Curr Oncol; 2020 Apr; 27(2):e182-e190. PubMed ID: 32489267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
    Graziano F; Humar B; Guilford P
    Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review.
    Corso G; Montagna G; Figueiredo J; La Vecchia C; Fumagalli Romario U; Fernandes MS; Seixas S; Roviello F; Trovato C; Guerini-Rocco E; Fusco N; Pravettoni G; Petrocchi S; Rotili A; Massari G; Magnoni F; De Lorenzi F; Bottoni M; Galimberti V; Sanches JM; Calvello M; Seruca R; Bonanni B
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome.
    Molinaro V; Pensotti V; Marabelli M; Feroce I; Barile M; Pozzi S; Laghi L; Serrano D; Bernard L; Bonanni B; Ranzani GN
    Genes Chromosomes Cancer; 2014 May; 53(5):432-45. PubMed ID: 24493355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panel testing reveals nonsense and missense CDH1 mutations in families without hereditary diffuse gastric cancer.
    Huynh JM; Laukaitis CM
    Mol Genet Genomic Med; 2016 Mar; 4(2):232-6. PubMed ID: 27064202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition to gastric cancer.
    Petrovchich I; Ford JM
    Semin Oncol; 2016 Oct; 43(5):554-559. PubMed ID: 27899187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of
    Guerra J; Pinto C; Pinto P; Pinheiro M; Santos C; Peixoto A; Escudeiro C; Barbosa A; Porto M; Francisco I; Lopes P; Isidoro AR; Cunha AL; Albuquerque C; Claro I; Oliveira C; Silva J; Teixeira MR
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
    Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
    Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of c.1531C>T Pathogenic Variant in the
    Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.